Latest Breaking News On - தத்தா மேகே நிறுவனம் - Page 1 : comparemela.com

Industry > Industry monitor > Healthcare 29 April 2021 Ayush 64, a poly-herbal preparation originally developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) for the treatment of Malaria, in the year 1980 and now repurposed for the treatment Covid-19, has been found to be useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care. Ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) recently collaborated for robust multi-centre clinical trials to evaluate the safety and efficacy of Ayush 64 in the management of mild to moderate Covid-19 patients. Clinical trials were conducted at KGMU, Lucknow; DMIMS, Wardha and BMC Covid Centre, Mumbai, involving 70 participants in each arm. Dr Chopra said Ayush 64 as an adjunct to standard of care (SoC) showed significant improvement and thus lesser period of hospitalisation compared to the only SoC procedure, Dr Arvind Chopra, director, Centre for R

Uttar pradeshArvind chopraBhushan patwardhanCentre for rheumatic diseasesInstitute of medical education researchDepartment of health researchNational task force on covidDevelopment task force on covidAyush researchCovid centreAyurvedic sciencesMinistry of ayushCentral council for researchCouncil of scientificIndian council of medical researchGovernment medical college